USPTO 2015–2025 USPTO PatentsView US Corporation

Nutrition & Biosciences USA 4, Inc.

USPTO PatentsView assignee record - 68 granted patents across 48 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08B (POLYSACCHARIDES; Derivatives Thereof).

RSS updates for this company

The verdict

According to USPTO PatentsView, Nutrition ranks #5,100 of 49,997 tracked US assignees by granted-patent volume, with 68 patents across 48 technology areas.

#5,100
of 49,997 US assignees by volume
Top 1%
by Innovation Score (67.0/100)
20.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R5100 · US Corporation #5,100 · 68 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 68 grants
  • UPPER-Q #5,100/49,997
  • PHOTO-FINISH Medtronic Holding Sarl
  • CPC-WIDE C08B · 48 areas
  • INNOV-STRONG 67.0/100
  • CLAIMS-RICH 20.0 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Medtronic Holding Company Sarl (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Nutrition

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Nutrition's Innovation Score is 67.0/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Nutrition's grants concentrate

Nutrition & Biosciences USA 4, Inc. is a focused PatentsView assignee: 48 CPC subclasses with 75% of grants classified under C08B (POLYSACCHARIDES; Derivatives Thereof). Peak complete grant year is 2021 (18 grants) versus a trough of 13 in 2023. By volume, Nutrition sits between Medtronic Holding Company Sarl and Ostendo Technologies, Inc..

Nutrition's three-year grant acceleration

Nutrition & Biosciences USA 4, Inc. shows 43 grants in 2022–2024 against only 18 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Nutrition's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Nutrition holds 68 patents at rank #5,097, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Nutrition

By rank, the assignees closest to #5,097 in granted patent volume.

Leaders in C08B (Polysaccharides)

Other assignees with the most granted patents in Nutrition's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Nutrition, neither rank-band nor same-CPC leaders (those blocks stay above).

Nutrition's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

5101520 20212022202320242025 7
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Nutrition & Biosciences USA 4, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 18 26.5%
2022 14 20.6%
2023 13 19.1%
2024 16 23.5%
2025partial year 7 10.3%

Which technologies does Nutrition & Biosciences USA 4, Inc. patent most?

Top 15 of 48 technology areas

Where it ranks

Overall rank by patents

#5,100

of 49,997 tracked assignees

Innovation Score

67.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Nutrition & Biosciences USA 4, Inc.'s patent record in context - here's where to go next.

  • Nutrition & Biosciences USA 4, Inc.'s lead technology class is C08B (POLYSACCHARIDES; Derivatives Thereof), 75% of its portfolio - see every assignee active in that class. Explore C08B
  • Ranked #5,100 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Nutrition & Biosciences USA 4, Inc. against Medtronic Holding Company Sarl, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 67.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.